Palmitoyl acyltransferase ZDHHC7 inhibits androgen receptor and suppresses prostate cancer

[1]  A. Shilatifard,et al.  PALI1 promotes tumor growth through competitive recruitment of PRC2 to G9A-target chromatin for dual epigenetic silencing. , 2022, Molecular cell.

[2]  A. Jemal,et al.  Cancer statistics, 2022 , 2022, CA: a cancer journal for clinicians.

[3]  Ximing J. Yang,et al.  HOXB13 suppresses de novo lipogenesis through HDAC3-mediated epigenetic reprogramming in prostate cancer , 2021, Nature Genetics.

[4]  Jindan Yu,et al.  Posttranslational regulation of FOXA1 by Polycomb and BUB3/USP7 deubiquitin complex in prostate cancer , 2021, Science Advances.

[5]  L. Chamberlain,et al.  Regulatory effects of post-translational modifications on zDHHC S-acyltransferases , 2020, The Journal of Biological Chemistry.

[6]  M. Loda,et al.  Lipogenic signalling modulates prostate cancer cell adhesion and migration via modification of Rho GTPases , 2020, Oncogene.

[7]  Jindan Yu,et al.  Altered chromatin recruitment by FOXA1 mutations promotes androgen independence and prostate cancer progression , 2019, Cell Research.

[8]  A. Bielawska,et al.  Dietary palmitate cooperates with Src kinase to promote prostate tumor progression , 2019, The Prostate.

[9]  S. Srivastava,et al.  Kinase-Inactivated EGFR Is Required for the Survival of Wild-Type EGFR-Expressing Cancer Cells Treated with Tyrosine Kinase Inhibitors , 2019, International journal of molecular sciences.

[10]  Ximing J. Yang,et al.  Activation of MAPK Signaling by CXCR7 Leads to Enzalutamide Resistance in Prostate Cancer. , 2019, Cancer research.

[11]  J. Licht,et al.  Polycomb- and Methylation-Independent Roles of EZH2 as a Transcription Activator , 2018, Cell reports.

[12]  Jindan Yu,et al.  TRIM28 protects TRIM24 from SPOP-mediated degradation and promotes prostate cancer progression , 2018, Nature Communications.

[13]  S. Dixon,et al.  Protein palmitoylation and cancer , 2018, EMBO reports.

[14]  Hening Lin,et al.  Protein Lipidation: Occurrence, Mechanisms, Biological Functions, and Enabling Technologies. , 2018, Chemical reviews.

[15]  G. Jarugumilli,et al.  ZDHHC7-Mediated S-Palmitoylation of Scribble Regulates Cell Polarity , 2016, Nature chemical biology.

[16]  S. Gambhir,et al.  Androgen Receptor Splice Variants Dimerize to Transactivate Target Genes. , 2015, Cancer research.

[17]  M. Shipston,et al.  The physiology of protein S-acylation. , 2015, Physiological reviews.

[18]  J. Durivault,et al.  Fas palmitoylation by the palmitoyl acyltransferase DHHC7 regulates Fas stability , 2014, Cell Death and Differentiation.

[19]  W. Isaacs,et al.  AR-V7 and resistance to enzalutamide and abiraterone in prostate cancer. , 2014, The New England journal of medicine.

[20]  S. Balk,et al.  Androgen receptor functions in castration-resistant prostate cancer and mechanisms of resistance to new agents targeting the androgen axis , 2014, Oncogene.

[21]  Jindan Yu,et al.  Cooperativity and Equilibrium with FOXA1 Define the Androgen Receptor Transcriptional Program , 2014, Nature Communications.

[22]  D. Berney,et al.  Identification of ZDHHC14 as a novel human tumour suppressor gene , 2014, The Journal of pathology.

[23]  Jun Liu,et al.  Cooperation between Polycomb and androgen receptor during oncogenic transformation. , 2012, Genome research.

[24]  R. Deschenes,et al.  DHHC-7 and -21 are palmitoylacyltransferases for sex steroid receptors , 2012, Molecular biology of the cell.

[25]  Sanaz Memarzadeh,et al.  Differential transformation capacity of Src family kinases during the initiation of prostate cancer , 2011, Proceedings of the National Academy of Sciences.

[26]  E. Lundberg,et al.  Towards a knowledge-based Human Protein Atlas , 2010, Nature Biotechnology.

[27]  P. Nelson,et al.  Castration resistance in human prostate cancer is conferred by a frequently occurring androgen receptor splice variant. , 2010, The Journal of clinical investigation.

[28]  Zhaohui S. Qin,et al.  An integrated network of androgen receptor, polycomb, and TMPRSS2-ERG gene fusions in prostate cancer progression. , 2010, Cancer cell.

[29]  M. Loda,et al.  Overexpression of fatty acid synthase is associated with palmitoylation of Wnt1 and cytoplasmic stabilization of β-catenin in prostate cancer , 2008, Laboratory Investigation.

[30]  M. Loda,et al.  Caveolin-1 interacts with a lipid raft-associated population of fatty acid synthase , 2008 .

[31]  M. Loda,et al.  Caveolin-1 interacts with a lipid raft-associated population of fatty acid synthase , 2008, Cell cycle.

[32]  D. Tindall,et al.  Androgen receptor (AR) coregulators: a diversity of functions converging on and regulating the AR transcriptional complex. , 2007, Endocrine reviews.

[33]  R. Sainson,et al.  A Conserved Mechanism for Steroid Receptor Translocation to the Plasma Membrane* , 2007, Journal of Biological Chemistry.

[34]  Bin Zhou,et al.  The Palmitoylation of Metastasis Suppressor KAI1/CD82 Is Important for Its Motility- and Invasiveness-Inhibitory Activity , 2004, Cancer Research.

[35]  C. Heinlein,et al.  Androgen receptor in prostate cancer. , 2004, Endocrine reviews.

[36]  C. Huggins,et al.  Studies on prostatic cancer. I. The effect of castration, of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate. 1941. , 2002, The Journal of urology.

[37]  C. Huggins,et al.  Studies on prostatic cancer: I. The effect of castration, of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate , 1941, CA: a cancer journal for clinicians.